Innoventric is a structural heart medical device company engaged primarily in the development of percutaneous solutions for tricuspid regurgitation and right heart disease.
The company has developed an easily deployable percutaneous functional tricuspid valve replacement that utilizes cross-caval anchoring and an innovative multi-valve design for long-lasting blood flow regulation.
Innoventric is dedicated to the development of simple yet sophisticated transcatheter solutions to significantly improve the quality of life and life span of patients with structural heart disease.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Innoventric Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Oct 29, 2024
www.calcalistech.com
Innoventric secures $28.5M to reduce medical need for surgical valve replacement and general anesthesia | CTech
#Investment
Nov 1, 2021
www.prnewswire.com
Israeli Medical Device Startup, Innoventric Ltd., Wins the Prestigious Horizon Europe Grant and Secures US $14M in Series A Investment